New York Oncology Hematology PC - Clifton Park — Clifton Park, New York

New York Oncology Hematology PC - Clifton Park is a clinical research site located in Clifton Park, New York, United States 12065.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

New York Oncology Hematology PC - Clifton Park has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7.

Sponsors: National Cancer Institute (NCI), GOG Foundation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Clifton Park

Browse all research sites in New York · View every site in Clifton Park

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology PC - Clifton Park?

New York Oncology Hematology PC - Clifton Park has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology PC - Clifton Park conducted?

New York Oncology Hematology PC - Clifton Park has 10 clinical trials on record, with 3 currently active. Their work covers Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7.

Is New York Oncology Hematology PC - Clifton Park accredited by Crixeo Clinical Trials?

New York Oncology Hematology PC - Clifton Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology PC - Clifton Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.